首页> 外国专利> Utilization active agonist effect of opioid receptors nu and an antagonistic effect opioid receptor, as combined for the treatment of a cancer drug substances.

Utilization active agonist effect of opioid receptors nu and an antagonistic effect opioid receptor, as combined for the treatment of a cancer drug substances.

机译:利用阿片样物质受体nu的主动激动剂作用和阿片样物质受体的拮抗作用,共同治疗癌症药物。

摘要

Use of active substances with an effect agonist μ opioid receptors, chosen from morphine 6-glucuronide, methadone, pethidine, fentanyl, tramadol, pentazocine, buprenorphine, tilidine, levomethadone, piritramide, levacetylmethadol, codeine, oxycodone, hydromorphone , dihydrocodeine, diamorphine, sufentanil, alfentanil, remifentanil, nalbuphine, butorphanol, their salts and glucuronides as well as mixtures of these substances or substances having an antagonistic effect of opioid receptors, chosen from naloxone and naltrexone and their salts, and mixtures of these substances as combined for the treatment of cancer drugs.
机译:具有有效激动剂μ阿片样物质受体的活性物质的使用,选自吗啡6-葡糖醛酸,美沙酮,哌替啶,芬太尼,曲马多,喷他佐辛,丁丙诺啡,替尼定,左美沙酮,吡咯烷酰胺,乙酰乙酰甲胺,可待因,羟考酮,氢吗啡酮,二氢吗啡,阿芬太尼,瑞芬太尼,纳布啡,布托啡诺,它们的盐和葡糖醛酸化物以及这些物质或具有阿片受体拮抗作用的物质的混合物,选自纳洛酮和纳曲酮及其盐,以及这些物质的混合物,用于治疗癌症药物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号